Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant <i>Staphylococcus aureus</i> Infections

Design and Preclinical Development of a Phage Product for the Treatment of Antibiotic-Resistant <i>Staphylococcus aureus</i> Infections

Bacteriophages, viruses that only kill specific bacteria, are receiving substantial attention as nontraditional antibacterial agents that may help alleviate the growing antibiotic resistance problem in medicine. We describe the design and preclinical development of AB-SA01, a fixed-composition bacte...

Full description

Bibliographic Details
Main Authors: Susan M. Lehman, Gillian Mearns, Deborah Rankin, Robert A. Cole, Frenk Smrekar, Steven D. Branston, Sandra Morales
Format: Article
Language:English
Published: MDPI AG 2019-01-01
Series:Viruses
Subjects:
bacteriophage
phage therapy
<i>Staphylococcus aureus</i>
biofilm
antimicrobial
frequency of resistance
phage sensitivity
resistance management
nontraditional antibacterial
Online Access:https://www.mdpi.com/1999-4915/11/1/88

Internet

https://www.mdpi.com/1999-4915/11/1/88

Similar Items